Načítá se...
Emerging Pharmacologic Therapies for Heart Failure With Reduced Ejection Fraction
The global burden of heart failure has reached epidemic proportions with tremendous health and economic consequences. Sodium glucose cotransporter 2 inhibitors, vericiguat, and omecamtiv mecarbil are novel agents that promise to blunt the high residual risk of heart failure with reduced ejection fra...
Uloženo v:
| Vydáno v: | CJC Open |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8134937/ https://ncbi.nlm.nih.gov/pubmed/34027369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjco.2021.01.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|